Clinic
Scott & White Memorial Hospital
Scott & White Memorial Hospital was paid $55.08M by Medicaid between Aug 2018 and Dec 2024, across 339 billing codes. Its largest line is 99284, emergency room visit (serious) — 26% of everything it billed.
33Billing provider infoSCOTT & WHITE MEMORIAL HOSPITAL
TEMPLE, TX 76508
TEMPLE, TX 76508
33aNPI1477516466assigned 04/10/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$55.08M
24GClaims1,084,556
24DCodes billed339
24AFirst – last monthAug 2018 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#8 of 320
Median peer was paid$205K
This provider vs. median269×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 31 | $108.75 | |
| 2019 | 1,519 | $42K | |
| 2020 | 28,622 | $1.62M | |
| 2021 | 335,152 | $16.42M | |
| 2022 | 344,597 | $19.24M | |
| 2023 | 261,526 | $13.16M | |
| 2024incomplete | 113,109 | $4.60M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 26% | 33,413 | 31,192 | $14.13M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 177,660 | 160,890 | $10.53M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11% | 100,656 | 93,612 | $6.20M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.1% | 10,376 | 9,513 | $5.03M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.5% | 29,327 | 27,748 | $1.38M |
| 59025 | Fetal non-stress test | 2.0% | 7,574 | 5,116 | $1.13M |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2.0% | 19,782 | 18,311 | $1.09M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.8% | 1,408 | 1,335 | $1.01M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.7% | 13,593 | 12,228 | $927K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.6% | 18,249 | 17,507 | $874K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.2% | 12,427 | 11,537 | $676K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.2% | 10,914 | 10,008 | $656K |
327 more codes
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.1% | 56,317 | $605K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.1% | 13,009 | $580K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 31,871 | $450K |
| 80053 | Comprehensive metabolic panel | <1% | 41,896 | $404K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 1,181 | $404K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 10,731 | $395K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 10,379 | $380K |
| 93325 | <1% | 2,412 | $345K | |
| Q3014 | Telehealth originating site facility fee | <1% | 6,692 | $336K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 8,508 | $309K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 45,460 | $304K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 370 | $299K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 1,106 | $295K |
| 90837 | Psychotherapy session, about an hour | <1% | 3,426 | $260K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,269 | $240K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 1,489 | $221K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 6,840 | $203K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,797 | $186K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 5,742 | $185K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 2,823 | $184K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 66 | $156K |
| 94010 | <1% | 973 | $156K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 6,380 | $154K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 3,977 | $152K |
| 64642 | <1% | 874 | $144K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 6,026 | $137K |
| 93320 | <1% | 799 | $123K | |
| 95813 | <1% | 316 | $102K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 4,089 | $100K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 3,390 | $94K |
| 86850 | <1% | 3,216 | $92K | |
| 87632 | <1% | 384 | $91K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 8,641 | $90K |
| 92567 | <1% | 2,495 | $87K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 356 | $81K |
| 96160 | <1% | 5,372 | $80K | |
| 92579 | <1% | 828 | $78K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 10,842 | $77K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 916 | $76K |
| 76770 | <1% | 480 | $75K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 79,031 | $73K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,556 | $72K |
| 87428 | <1% | 1,213 | $69K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 4,398 | $68K |
| 81001 | <1% | 22,104 | $68K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,350 | $67K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 772 | $66K |
| 84702 | <1% | 7,481 | $61K | |
| 81513 | <1% | 687 | $61K | |
| 95716 | <1% | 52 | $58K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 342 | $55K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 8,598 | $54K |
| 93321 | <1% | 324 | $53K | |
| 87081 | <1% | 5,072 | $50K | |
| 92588 | <1% | 334 | $44K | |
| 80061 | Lipid panel | <1% | 6,927 | $42K |
| 73630 | <1% | 1,458 | $40K | |
| 86803 | <1% | 2,672 | $40K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,207 | $39K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,277 | $38K |
| 87653 | <1% | 736 | $37K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 470 | $35K |
| 86780 | <1% | 2,454 | $35K | |
| 90785 | <1% | 743 | $34K | |
| 92557 | <1% | 398 | $34K | |
| 76830 | Ultrasound, transvaginal | <1% | 410 | $32K |
| 0001A | <1% | 2,427 | $32K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 709 | $31K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 755 | $31K |
| 0002A | <1% | 2,261 | $30K | |
| 73110 | <1% | 525 | $30K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 534 | $29K |
| 95874 | <1% | 1,099 | $29K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 94 | $29K |
| 85027 | <1% | 5,385 | $28K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 174 | $28K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,059 | $28K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,305 | $27K |
| 86762 | <1% | 1,414 | $24K | |
| 90715 | <1% | 1,232 | $24K | |
| 11750 | <1% | 96 | $24K | |
| 95117 | <1% | 1,873 | $23K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 177 | $23K |
| 64643 | <1% | 903 | $22K | |
| 87340 | <1% | 2,398 | $21K | |
| 86592 | <1% | 4,013 | $20K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,994 | $20K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 397 | $20K |
| 85610 | <1% | 5,867 | $20K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,234 | $19K |
| 80081 | <1% | 207 | $19K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,329 | $19K |
| 90670 | <1% | 135 | $19K | |
| 82728 | <1% | 2,821 | $18K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 606 | $17K |
| 81003 | <1% | 6,279 | $16K | |
| 82950 | <1% | 2,653 | $16K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 502 | $15K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,160 | $15K |
| 94664 | <1% | 546 | $14K | |
| 94762 | <1% | 358 | $14K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,393 | $14K |
| 84439 | <1% | 2,709 | $14K | |
| 94760 | <1% | 720 | $14K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 209 | $14K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 496 | $14K |
| 96127 | <1% | 982 | $13K | |
| 72082 | <1% | 138 | $13K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 945 | $13K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 13 | $13K |
| 87807 | <1% | 749 | $13K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,381 | $12K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 240 | $11K |
| 83880 | <1% | 2,066 | $11K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 104 | $11K |
| 25600 | <1% | 48 | $11K | |
| 74018 | <1% | 242 | $11K | |
| 93304 | <1% | 47 | $11K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 984 | $11K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 28 | $11K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 43 | $10K |
| 84703 | <1% | 1,784 | $9K | |
| 76801 | <1% | 87 | $9K | |
| 92551 | <1% | 400 | $9K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 271 | $9K |
| 83690 | <1% | 3,595 | $9K | |
| 36416 | <1% | 3,335 | $8K | |
| 84484 | <1% | 3,454 | $8K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 102 | $8K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 355 | $8K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 321 | $8K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 662 | $8K |
| 83550 | <1% | 2,211 | $7K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 86 | $7K |
| 90461 | <1% | 349 | $7K | |
| 90686 | <1% | 1,539 | $7K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,132 | $7K |
| 20610 | <1% | 765 | $7K | |
| 83735 | <1% | 4,215 | $7K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,355 | $6K |
| 85045 | <1% | 1,273 | $6K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,071 | $6K |
| 92201 | <1% | 233 | $6K | |
| 83540 | <1% | 2,383 | $6K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 146 | $5K |
| 73564 | <1% | 69 | $5K | |
| 95812 | <1% | 15 | $5K | |
| 82570 | <1% | 3,853 | $5K | |
| 73080 | <1% | 101 | $5K | |
| 86901 | <1% | 2,259 | $5K | |
| 86900 | <1% | 2,266 | $5K | |
| 95700 | <1% | 50 | $5K | |
| 99070 | <1% | 384 | $4K | |
| 76825 | <1% | 14 | $4K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 33 | $4K |
| 0071A | <1% | 255 | $4K | |
| 90723 | <1% | 75 | $4K | |
| 96161 | <1% | 2,708 | $4K | |
| 85018 | <1% | 1,778 | $4K | |
| 87210 | <1% | 895 | $4K | |
| 85014 | <1% | 1,986 | $4K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,925 | $3K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 68 | $3K |
| 0072A | <1% | 204 | $3K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 60 | $3K |
| 99173 | <1% | 556 | $3K | |
| 87481 | <1% | 600 | $3K | |
| 90678 | <1% | 13 | $3K | |
| 69210 | <1% | 60 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 149 | $2K |
| 72170 | <1% | 99 | $2K | |
| 76642 | <1% | 40 | $2K | |
| 92552 | <1% | 52 | $2K | |
| 96376 | <1% | 151 | $2K | |
| 84100 | <1% | 1,768 | $2K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 26 | $2K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 347 | $2K |
| 86787 | <1% | 131 | $2K | |
| 73030 | <1% | 362 | $2K | |
| 73610 | <1% | 134 | $2K | |
| 82043 | <1% | 2,848 | $2K | |
| 83970 | <1% | 1,038 | $2K | |
| 90648 | <1% | 160 | $2K | |
| 87186 | <1% | 1,546 | $2K | |
| 84550 | <1% | 406 | $1K | |
| 85730 | <1% | 1,133 | $1K | |
| 90680 | <1% | 56 | $1K | |
| 73130 | <1% | 114 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 722 | $1K |
| 86140 | <1% | 1,191 | $1K | |
| 92523 | <1% | 14 | $1K | |
| 82784 | <1% | 205 | $1K | |
| 86364 | <1% | 45 | $1K | |
| 93788 | <1% | 12 | $1K | |
| 88720 | <1% | 208 | $1K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 85 | $1K |
| 86255 | <1% | 82 | $1K | |
| 82607 | <1% | 1,241 | $1K | |
| 82805 | <1% | 145 | $1K | |
| 87040 | <1% | 166 | $1K | |
| 57452 | <1% | 12 | $924.17 | |
| 77073 | <1% | 12 | $895.67 | |
| 83605 | <1% | 546 | $895.19 | |
| 0031A | <1% | 55 | $877.53 | |
| 92060 | <1% | 12 | $874.66 | |
| 80076 | <1% | 416 | $866.47 | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 16 | $824.78 |
| 73090 | <1% | 27 | $805.86 | |
| 73562 | <1% | 147 | $786.06 | |
| 80069 | <1% | 1,488 | $782.51 | |
| 87430 | <1% | 63 | $776.60 | |
| 82565 | <1% | 1,180 | $739.70 | |
| 73502 | <1% | 98 | $710.81 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,566 | $697.04 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 563 | $688.85 |
| 84156 | <1% | 1,108 | $678.61 | |
| 99170 | <1% | 39 | $662.40 | |
| C1769 | Guide wire | <1% | 98 | $661.73 |
| 83615 | <1% | 373 | $654.55 | |
| 71250 | <1% | 28 | $646.62 | |
| 90836 | <1% | 16 | $609.44 | |
| 84155 | <1% | 1,057 | $552.77 | |
| 84075 | <1% | 803 | $549.18 | |
| 20611 | <1% | 38 | $539.85 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,003 | $535.51 |
| 92002 | <1% | 71 | $528.54 | |
| 92133 | <1% | 66 | $524.07 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,507 | $520.96 |
| 90656 | <1% | 234 | $483.00 | |
| 74019 | <1% | 14 | $449.90 | |
| 83516 | <1% | 56 | $443.64 | |
| 85380 | <1% | 338 | $417.06 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 15 | $396.00 |
| 93923 | <1% | 25 | $393.82 | |
| 83655 | <1% | 24 | $393.79 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 2,258 | $391.99 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 32 | $383.23 |
| 85652 | <1% | 954 | $372.00 | |
| 77066 | Tomosynthesis, mammo | <1% | 13 | $370.26 |
| 73590 | <1% | 14 | $334.30 | |
| 82040 | <1% | 60 | $331.64 | |
| 82962 | <1% | 2,389 | $331.35 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,414 | $328.67 |
| 83002 | <1% | 12 | $315.10 | |
| 90633 | <1% | 14 | $307.95 | |
| 84460 | <1% | 750 | $298.47 | |
| 81025 | <1% | 50 | $297.37 | |
| 87070 | <1% | 147 | $283.92 | |
| 82951 | <1% | 12 | $271.08 | |
| 0004A | <1% | 35 | $227.20 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 828 | $224.12 |
| 98960 | <1% | 16 | $222.15 | |
| 83020 | <1% | 12 | $218.14 | |
| 0052A | <1% | 12 | $209.80 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 247 | $207.10 |
| 82803 | <1% | 44 | $197.10 | |
| 84520 | <1% | 110 | $194.31 | |
| 84153 | <1% | 108 | $185.40 | |
| 87205 | <1% | 163 | $151.59 | |
| 84132 | <1% | 140 | $142.45 | |
| 90661 | <1% | 18 | $139.80 | |
| 97162 | <1% | 14 | $129.52 | |
| 93971 | <1% | 12 | $128.63 | |
| 83525 | <1% | 14 | $124.20 | |
| 87077 | <1% | 244 | $122.22 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 103 | $122.11 |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 31 | $119.37 |
| 94729 | <1% | 53 | $114.52 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 317 | $111.13 |
| 99152 | <1% | 30 | $111.00 | |
| 93296 | <1% | 24 | $108.25 | |
| 82947 | <1% | 59 | $107.03 | |
| 51705 | <1% | 17 | $103.54 | |
| 90677 | <1% | 29 | $100.70 | |
| 82378 | <1% | 16 | $95.58 | |
| 64493 | <1% | 14 | $95.42 | |
| 84295 | <1% | 26 | $93.01 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 469 | $87.38 |
| 82140 | <1% | 14 | $85.68 | |
| 82952 | <1% | 12 | $82.56 | |
| 0003A | <1% | 111 | $80.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 345 | $79.74 |
| 92202 | <1% | 65 | $78.35 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 369 | $76.64 |
| 82746 | <1% | 73 | $74.10 | |
| 87799 | <1% | 19 | $71.97 | |
| 86038 | <1% | 47 | $71.12 | |
| 82465 | <1% | 15 | $65.35 | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | <1% | 180 | $59.78 |
| 80197 | <1% | 1,040 | $56.49 | |
| 82247 | <1% | 17 | $54.86 | |
| 82550 | <1% | 57 | $49.23 | |
| 86480 | <1% | 12 | $48.93 | |
| 85007 | <1% | 136 | $45.07 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 782 | $41.22 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 15 | $35.72 |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | <1% | 141 | $34.60 |
| 92134 | <1% | 550 | $28.24 | |
| 92015 | Determination of refractive state | <1% | 39 | $28.01 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 15 | $20.19 |
| 80051 | <1% | 13 | $18.49 | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,165 | $11.80 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 20 | $10.04 |
| 99495 | <1% | 12 | $3.57 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 48 | $3.23 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 143 | $2.37 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 41 | $1.46 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 5,013 | $0.05 |
| 90662 | 0% | 408 | $0.00 | |
| 90653 | 0% | 59 | $0.00 | |
| 94060 | 0% | 38 | $0.00 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 29 | $0.00 |
| 77002 | 0% | 15 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 1,243 | $0.00 |
| 90694 | 0% | 78 | $0.00 | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 0% | 51 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 96 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 67 | $0.00 |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | 0% | 81 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 13 | $0.00 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 0% | 12 | $0.00 |
| 99406 | 0% | 25 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 0% | 29 | $0.00 |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 0% | 12 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 57 | $0.00 |
| 82330 | 0% | 14 | $0.00 | |
| 64494 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialOLSEN, CHRISTOPHER (CFO)
| Provider | Location | Paid |
|---|---|---|
| Scott & White Memorial Hospital | Temple, TX | $1.55M |
| Christopher L. Olsen, DDS PLLC | Fairmont, MN | $815K |
| Scott & White Memorial Hospital | Waco, TX | $128K |
| Christopher Olsen, DDS LLC | North Pole, AK | $33K |
| Scott & White Memorial Hospital | Temple, TX | $6K |
| Scott & White Memorial Hospital | Killeen, TX | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.